Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Mutations in PKHD1L1 Cause FCMTE in Chinese Families via Excitation of PKA Activity in Cortex

Author:Yu, Peimin   Wang, Yue   Xu, Lan   Ge, Yan   Li, Xiantao   Qiao, Kai   Ding, Ding   Zhu, Gouxing   Hong, Zhen   

Session Name:S29: Epilepsy: Basic Science and Mechanisms  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S29.005  

Author Institution:Department of Neurology, Huashan Hospital, Fudan University , China, People's Republic of  Department of Critical care medicine, Huashan Hospital, Fudan University, China, People's Republic of  

Clinical Updates from the Elsunersen Emergency Use Program: A Novel ASO for Treatment of Early Onset SCN2A Developmental and Epileptic Encephalopathy

Author:Petrou, Steven   Wagner, Matias   Borggraefe, Ingo   Wheless, James   Troedson, Christopher   Howell, Katherine   Burns, William   Frizzo, Silvana   Horton, Robert   Jacotin, Henry   Patel, Dharit   Motel, William   Spar, Brian   Souza, Marcio   

Session Name:S29: Epilepsy: Basic Science and Mechanisms  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S29.010  

Author Institution:Praxis Precision Medicines, MA  Ludwig Maximilians University Hospital, Germany  UTHSC-Pediatric Neurology, Memphis, TN  The Children’s Hospital at Westmead, Australia  Department of Neurology, Royal Children's Hospital, Australia  Nationwide Childrens, OH  

Polyneuropathy Symptoms Precede Diagnosis of Cardiomyopathy Among Individuals with Transthyretin Amyloidosis

Author:Halabi, Anasheh   Sanjurjo, Victoria   Papas, Mia   Shea, Amy   Davies, Marie   Venditto, John   Towne, Meghan   Li, Xiaolei   Young, James   Nair, Hemanth   Hanna, Mazen   

Session Name:S33: Autonomic Disorders  

Topic:Autonomic Disorders  

Program Number:S33.004  

Author Institution:UCLA Department of Neurology, Los Angeles, CA  Ionis, Carlsbad, CA  AstraZeneca, Wilmington, DE  Clarivate Analytics, Toronto, ON, Canada  Clarivate Analytics, Alexandria, VA  Cleveland Clinic, Cleveland, OH  

Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study

Author:Bar-Or, Amit   Oh, Jiwon   Giovannoni, Gavin   Sormani, Maria Pia   Weber, Martin S.   Stoll, Sharon   Nicholas, Jacqueline A.   Büdingen, H.-Christian von   Lopez, Jon   Roberts, Louise   Triyatni, Miriam   Qi, Qi   Ratchford, John N.   Napieralski, Julie   Goodyear, Alexandra   Hauser, Stephen L.   Kappos, Ludwig   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:S40.004  

Author Institution:Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada  Queen Mary University of London, London, UK, London, United Kingdom  University of Genoa, Genoa, Italy, Genoa, Italy  Institute of Neuropathology and Department of Neurology, University Medical Center and Fraunhofer Institute for Translational Medicine and Pharmacology, Göttingen, Germany, Göttingen, Germany  Advocare Stoll Medical Group, Philadelphia, PA, USA, Philadelphia, PA  OhioHealth Multiple Sclerosis Centre, Riverside Methodist Hospital, Columbus, OH, USA, Columbus, OH  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Genentech, Inc., South San Francisco, CA, USA, South San Francisco, CA  University of California San Francisco, San Francisco, CA, USA, San Francisco, CA  University Hospital and University Basel, Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Basel, Switzerland, Basel, Switzerland  

Convergent Causal Mapping of Memory and a Brain Stimulation Target for Memory Dysfunction

Author:Howard, Calvin   Kwon, Simon   Madan, Savir   Garimella, Arun   Schaper, Frederic   Kletenik, Isaiah   Ng, Marcus   Mosley, Philip   Grafman, Jordan   Bakshi, Rohit   Glanz, Bonnie   Fosdick, Lisa   Johnson, Amy   Colyer, Ryan   Lyketsos, Constantine   Morton-Dutton, Mae   Giftakis, John   Temel, Yasin   Rouhl, Rob   Ko, Ji Hyun   Schmahl, Rabea   Baldermann, Juan   Andrade-Montemayor, Pablo   Visser-Vandewalle, Veerle   Kuhn, Jens   Corbetta, Maurizio   Fisher, Robert   Picht, Thomas   Faust, Katharina   Hermiller, Molly   Voss, Joel   Chitnis, Tanuja   Kahana, Michael   Smith, Gwenn   Lozano, Andres   Siddiqi, Shan   Horn, Andreas   Fox, Michael   

Session Name:S42: Perspectives on Non-Alzheimer's Dementia Diagnostics and Therapeutics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:S42.007  

Author Institution:Calvin Howard, Boston, MA  Brigham and Women's Hospital, MA  Harvard Medical School, MA  Brigham and Women's, Boston, MA  BRIGHAM AND WOMEN’S HOSPITAL, Boston, MA  University of Manitoba, Winnipeg, MB, Canada  Queensland Brain Institute, Australia  Cognitive Neuroscience Section, Bethesda, MD  Harvard Medical School, Boston, MA  Brigham and Women'S Hospital, Boston, MA  Functional Neuromodulation Inc., MN  University of Manitoba, MB, Canada  University of Pennsylvania, PA  Johns Hopkins Medicine, Baltimore, MD  Medtronic, MN  Maastricht University Medical Center, Netherlands  University of Cologne, Germany  Department of Neurology, Washington University School of Medicine, Saint Louis, MO  Stanford University Medical Center, Palo Alto, CA  Charite Universitatmedizin Berlin, Germany  Dusseldorf University, Germany  Florida State University, FL  , University of Chicago, Chicago, IL  University of Pennsylvania, Merion Station, PA  Johns Hopkins Medicine, MD  Toronto Western Hosp, Toronto, ON, Canada  University Hospital Cologne, Germany  Brigham and Women's Hospital / Harvard Medical School, Boston, MA